Monday, 20 Nov 2017

You are here

EULAR 2017 – Day 1 Highlights

The Annual EULAR Congress kicked off this afternoon in Madrid with a number of new sessions devoted to:

  • Criteria revision in lupus, Sjogren's syndrome and the antiphospholipid syndrome
  • The cancer – autoimmunity balance and the lessons learned from checkpoint inhibitors and the development of Immune Related Adverse Events (IRAEs)
  • Wearable technologies
  • New EULAR campaign “Don’t Delay, Connect Today”.  (Promoting early diagnosis and the role of early interventions (including drug and lifestyle interventions)
  • Progress in Spondyloarthritis Management
  • Comorbidities and Rheumatic disease

Posters start tomorrow.

For many it was a day of meeting up with international colleagues and avoiding the 100 degree heat. (Burger King's air conditioning seems to be very appealing)

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

The RheumNow Week in Review - 17 November 2017

Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com. This week he covers FDA warnings on gout drugs, steroid use in Australia, biosimilars lost savings and methotrexate hepatotoxicity in psoriatic arthritis (PsA).

Podcast of ACR17 - Day 4

Care to learn what you missed at last weeks ACR 2017 meeting in San Diego?  Here are 4 one hour audio podcasts - each with a compliation of 2-4 minute reports from Drs. Cush, Kavanaugh, the RheumNow Faculty and other rheumatology thought leaders and researchers.  Another good way to learn from RheumNow.

The ACR17 RheumNow Week in Review - 10 November 2017

This special edition of the RheumNow Week in Review covers highlights of selected sessions from the 2017 ACR annual meeting in San Diego. Dr. Jack Cush reviews lupus and the microbiome, daily podcasts, pregnancy and lactation, osteoporosis drug holidays and screening for pulmonary hypertension.

Many thanks to the RheumNow Faculty for their work and expertise!

Podcast of ACR 17 - Day 3

Check out this compilation of our ACR17 Day 3 broadcasts, merged into a single one hour podcast !

ACR 2017 - Day 3 and 4 Highlights

Day 3 at the annual meeting was rich with information. Yet the most anticipated and best attended session was the Late Breaking Abstracts and the session revealing the new ACR/NPF Guidelines for Psoriatic Arthritis (more on the latter in another report).  Day 4 was full of review sessions and a modicum of original content and for me, the 7:30AM Rheumatology Roundup.